During the past decade, Illinois CancerCare-Kewanee Clinic conducted 202 clinical trials. In the 10-year time frame, 202 clinical trials started and 157 clinical trials were completed, i.e. on average, 77.7% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 86 clinical trials were completed. i.e. 89.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Kewanee Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 153 trials, followed by "Alliance for Clinical Trials in Oncology" with 74 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Kewanee Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 190 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Kewanee Clinic" are "Breast Cancer" (17 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (10 trials) and "Recurrent Ovarian Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Kewanee Clinic" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Kewanee Clinic" are "Drug" (279 trials), "Other" (209 trials), "Biological" (136 trials), "Procedure" (83 trials) and "Radiation" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (92 trials), "Quality-of-Life Assessment" (81 trials), "Questionnaire Administration" (55 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Kewanee Clinic" are 285 trials for "All" genders, 51 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Kewanee Clinic". undefined are not yet recruiting, 89 are recruiting, 138 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in Illinois CancerCare-Kewanee Clinic, 9 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Kewanee Clinic, 20 "Phase 1" clinical trials were conducted, 175 "Phase 2" clinical trials and 164 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".